FTD makes up about at least 5 to ten % of dementia cases.

A&G, Mayo Medical sign license agreement for new progranulin blood check for FTD Mayo Clinic today announced that Mayo Medical Laboratories has signed an contract with A&G Pharmaceutical, Inc. And will receive a nonexclusive license to certain patent privileges and proprietary antibody reagents for the detection and measurement of progranulin in bloodstream generic cialis . This agreement will let Mayo Clinic offer the first commercial blood check to predict progranulin mutation position in individuals suspected to possess frontotemporal dementia .